Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

martin_shkreli_2016

Martin Shkreli ordered to forfeit $7.36m ahead of fraud sentencing

March 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Martin Shkreli, pharma

Reviled pharma bro Martin Shkreli is experiencing another heavy dose of karma after a US judge ordered him to forfeit …
News
shutterstock_141105490

Uncovering trends in the future of real world data

March 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, AstraZeneca, feature, pharma, real world data, real world evidence

A new report has canvassed the intentions of industry players in the use of real world data and evidence over …
Feature
gilead-sciences

Gilead investigational data gives hope for HIV eradication in humans

March 5, 2018 Research and Development, Sales and Marketing Gilead, HIV, pharma

Gilead has lifted the curtain on new preclinical data on the efficacy of a combo therapy of GS-9620, its investigational …
News

FDA finds major manufacturing issues at key Aurobindo facility

March 5, 2018 Manufacturing and Production, Sales and Marketing Aurobindo, FDA, pharma

Indian pharmaceutical firm Aurobindo has been rocked by an USFDA review which identified nine major issues with its Unit 4 …
News
celgene_1_02

Celgene strikes $101m partnership in oncology, neurodegenerative and inflammatory

March 5, 2018 Research and Development, Sales and Marketing Cancer, Celgene, Vividion, inflammatory, neurodegenerative, oncology, pharma

Celgene has inked a new multi-year partnership with biotech firm Vividion Therapeutics to leverage the latter’s proteomics and chemistry platforms …
News
mri_credit_-_ptrump16

NHS trials “world-leading” initiative to cut prostate cancer diagnoses to just days

March 5, 2018 Research and Development, Sales and Marketing Cancer, MRI, NHS, pharma, prostate cancer

The NHS has revealed plans to cut the average diagnosis times for prostate cancer from six weeks to less than …
News

Abbvie and Biogen pull MS drug Zinbryta following urgent EMA safety review

March 5, 2018 Sales and Marketing AQbbvie, Biogen, EMA, Europe, mulyiple sclerosis, pharma, zinbryta

Biogen and Abbvie have announced their intention to voluntarily withdraw their multiple sclerosis therapy Zinbryta (daclizumab) from all global markets …
News
top_ten

Top Ten most popular articles on Pharmafile.com this week

March 2, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Alzheimer's, AstraZeneca, Botox, Celgene, EMA, FDA, Merck, Mylan, Pfizer, Roche, Takeda, ipsen, vaccines

We’re already into March and, trying to put a bad start to the year behind them on Alzheimer’s research, the …
News
endo-international

Endo granted injunction to block blood pressure competitor

March 2, 2018 Medical Communications, Sales and Marketing Endo, QuVa, Vasostrict, blood pressure, pharma, vasopressin

Generics and speciality pharma firm Endo International has revealed that it has been granted a preliminary injunction to block  competitor …
News
shutterstock_92671375

Artificial Cell Technologies CFO accused of stealing nearly $1m in company funds

March 2, 2018 Medical Communications, Sales and Marketing Artificial Cell Technologies, cfo, pharma

A high-ranking C-level executive of a US biotech start-up has been charged with embezzling almost $1 million from the company …
News
david_meek_web

Ipsen: Becoming a “development powerhouse”

March 1, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meek, Insider Interview, ipsen, pharma

Immediately following the release of impressive full year financials, Ipsen CEO David Meek speaks on how the company is hitting …
Feature
11149low_reception_in_darm

Merck/Pfizer’s Bavencio wins slight reprieve after NICE nod

March 1, 2018 Medical Communications, Sales and Marketing Bavencio, Merck, Pfizer, biotech, drugs, pharma, pharmaceutical

Just two weeks ago, Merck KGaA and Pfizer were hit with a major setback for their PD-L1 immunotherapy, Bavencio, after …
News
mylan_building

Mylan looks to muscle in on Allergan’s Botox territory

March 1, 2018 Sales and Marketing Botox, Mylan, Revance Therapeutics, biotech, drugs, epipen, pharma, pharmaceutical

Mylan announced, alongside its financials, that it had signed a global collaboration and licensing agreement with Revance Therapeutics to partner …
News
celgene_1_02

FDA refuses to review Celgene’s ozanimod in multiple sclerosis

February 28, 2018 Research and Development, Sales and Marketing Celgene, FDA, multiple sclerosis, ozanimod, pharma

Celgene has been dealt a heavy blow, revealing that the FDA has rejected its New Drug Application for its sphingosine …
News

AstraZeneca creates biotech spin-off, $250m in bank

February 28, 2018 Research and Development, Sales and Marketing AstraZeneca, Viela, biotech, drugs, pharma, pharmaceutical

Biotechs created from big pharma companies tend to have an easier start to life than most, and this is definitely …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025